Targeting the Pathways to Better Health

Our Mission

Intellikine is a clinical-stage company discovering and developing small molecule drugs that target signal transduction networks for the treatment of cancer and other diseases. Learn More

Pipeline

Our pipeline programs include both novel isoform-selective small molecule kinase inhibitors of the PI3K/Akt/mTOR signaling network.

Learn More

News

Takeda to Acquire Intellikine, Adding Two Novel Programs to its Oncology Pipeline

Learn More